Concepedia

Henry G. Hocking

HG

6

Publications

364

Citations

6

H-Index

2006

Active since

Affiliations

Atheris Laboratories (Switzerland)(Current)

Utrecht University

University of Geneva

KU Leuven

The University of Texas Health Science Center at Tyler

Henry G. Hocking is an author at Atheris Laboratories (Switzerland) specializing in immunology, drug discovery, and cell signaling.

ORCID

Top concepts

Publications per year

2006–2021

6

Publications

6

Critical Role of the C-Terminal Domains of Factor H in Regulating Complement Activation at Cell Surfaces

Viviana P. Ferreira, Andrew P. Herbert, Henry G. Hocking et al. · The Journal of Immunology · 2006 · 147 citations

Structure of the N-terminal Region of Complement Factor H and Conformational Implications of Disease-linked Sequence Variations

Henry G. Hocking, Andrew P. Herbert, David Kavanagh et al. · Journal of Biological Chemistry · 2008 · 62 citations · Full text

A novel µ‐conopeptide, CnIIIC, exerts potent and preferential inhibition of Na<sub>V</sub>1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors

Philippe Favreau, Évelyne Benoit, Henry G. Hocking et al. · British Journal of Pharmacology · 2012 · 57 citations · Full text

Multiple regulatory intrinsically disordered motifs control FOXO4 transcription factor binding and function

Benjamin Bourgeois, Tianshu Gui, Diana Hoogeboom et al. · Cell Reports · 2021 · 41 citations · Full text

Identification, structural and pharmacological characterization of τ-CnVA, a conopeptide that selectively interacts with somatostatin sst3 receptor

Christophe Pétrel, Henry G. Hocking, Morgane Reynaud et al. · Biochemical Pharmacology · 2013 · 34 citations

, , +7

Rows per page

1–5 of 6